Parexel Recognized as “Top CRO” to Work With in WCG CenterWatch Global Site Relationship Benchmark Survey
11 janv. 2022 15h30 HE
|
Parexel International LLC
BOSTON, and DURHAM, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Bolsters Regulatory and Access Offering with Key Appointment
11 janv. 2022 09h00 HE
|
Parexel International LLC
BOSTON, and Durham, N.C., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Releases Proprietary Biotech Market Research Report to Help Guide Companies on Navigating the Biotech Investment Landscape
06 janv. 2022 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
EQT Private Equity and Goldman Sachs Asset Management Complete Acquisition of Parexel
15 nov. 2021 17h03 HE
|
Parexel International LLC
EQT Private Equity and Goldman Sachs Asset Management committed to supporting Parexel’s Patients-First focus, track record of clinical excellence and dedication to qualityNewly-appointed Board of...
Parexel and Kyoto University Hospital Announce Strategic Alliance
20 oct. 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Strengthens Clinical Data and Digital Services Offering with Key Appointment
04 oct. 2021 08h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel’s Peyton Howell and Sofia Baig Named to 2021 PharmaVOICE 100
02 août 2021 08h00 HE
|
Parexel International LLC
Parexel leaders recognized as two of the 100 most inspiring people in life sciences for their transformative efforts to drive equity and innovation across the industry BOSTON and DURHAM, N.C., Aug. ...
Parexel Announces Innovative Patient Centric Partnership with Cancer Hospital Chinese Academy of Medical Sciences
28 juil. 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 28, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Announces Innovative Partnership with Rare Disease Foundation in China
22 juil. 2021 09h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 22, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...
Parexel Expands Asia/Pacific Capability through Enhanced Clinical Trial Supplies and Logistics Offering
07 juil. 2021 08h00 HE
|
Parexel International LLC
BOSTON and DURHAM, N.C., July 07, 2021 (GLOBE NEWSWIRE) -- Parexel, a leading global clinical research organization (CRO) focused on development and delivery of innovative new therapies to advance...